{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-058009","form_type":"8-K","ticker":"CAMP","cik":"0001736730","company_name":"Camp4 Therapeutics Corp","filed_at":"2025-12-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.281463+00:00","generated_at":"2026-05-16T12:45:51.406454+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"CAMP4 Therapeutics prices 5M share offering at $6.00, expects $28M net proceeds","bullets":["CAMP4 Therapeutics priced public offering of 5,000,000 shares of common stock at $6.00 per share.","Net proceeds expected to be approximately $28.0 million after underwriting discounts and expenses.","Underwriting agreement with Leerink Partners LLC; closing expected on or about December 19, 2025.","Executive officers, directors, and certain stockholders agreed to a 60-day lock-up on share sales."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-058009","json":"https://secwatch.observer/filing/0001628280-25-058009.json","markdown":"https://secwatch.observer/filing/0001628280-25-058009.md","text":"https://secwatch.observer/filing/0001628280-25-058009.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1736730/000162828025058009/0001628280-25-058009-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1736730/000162828025058009/camp-20251218.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:45:51.406454+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a14a5f1d06131aff8a240e3e2710f566a7b72ad4","claim":"Camp4 Therapeutics Corp entered into Underwriting Agreement with Leerink Partners LLC valued at Offering of 5,000,000 shares of common stock at $6.00 per share, net proceeds ~$28.0 million (effective 2025-12-18).","evidence_excerpt":"On December 18, 2025, CAMP4 Therapeutics Corporation (the “Company”), entered into an underwriting agreement (the “ Underwriting Agreement ”) with Leerink Partners LLC (“ Leerink Partners ”), relating to an offering of 5,000,000 shares (the “ Shares ”), of its common stock, par value $0.0001 per share (the “ Common Stock ”), at an offering price of $6.00 per Share.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1736730/000162828025058009/0001628280-25-058009-index.htm","confidence":0.99,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"Leerink Partners LLC"},{"label":"Value","value":"Offering of 5,000,000 shares of common stock at $6.00 per share, net proceeds ~$28.0 million"},{"label":"Effective","value":"2025-12-18"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}